Moreover, Wang et al. demonstrated that high SMYD3 expression predicted poor prognosis for patients with HCC and was found to be an independent prognostic factor for 5-year HCC tumor relapse [2]. Here, SMYD3 is linked to hepatocellular carcinoma.